PAX6 and Glucose intolerance: Consistently a study of aniridia patients with heterozygous PAX6 mutation found glucose intolerance characterized by impaired insulin secretion in all patients, demonstrating that the endocrine pancreas is sensitive to levels of PAX6 (17).